-
Feasibility of Circulating Tumor DNA Analysis in Dogs With Naturally-occurring Malignant and Benign Splenic Lesions
May 10, 2022In this study, tools previously validated for use in people were used to detect circulating tumor DNA (ctDNA) in the blood of dogs with splenic hemangiosarcoma.
Read Article -
A Novel Approach to Diagnosing Sepsis
April 25, 2022Ethos Discovery and MicroGen Vet are working together to perform next generation sequencing (NGS) on blood samples from dogs with sepsis to better define the spectrum of bacteria that cause the condition.
Read Article -
Ethos Discovery Paves the Way in the Fight Against Hemangiosarcoma
March 8, 2022Ethos Discovery is tackling hemangiosarcoma in the hopes of delivering curative outcomes for dogs through our multidisciplinary, collaborative hemangiosarcoma research program.
Read Article -
The Search for Effective Treatments for Canine Inflammatory Brain Disease
February 7, 2022Ethos Discovery hopes that NME will become a disease that no longer carries such a devastating prognosis and is instead associated with the ability for early diagnosis and preventative treatment options. A possible inflammatory-mediating treatment that we have identified for the treatment of NME in dogs is the administration of mesenchymal stem cells.
Read Article -
Provocative Question: “Does the Gut Microbiome Influence the Metastatic Cascade of Cancer?”
August 16, 2021The mechanisms by which the microbiota may influence metastasis and the break in dormancy may uncover therapeutic and prognostic tools useful in improving outcomes for cancer patients.
Read Article -
The Ethos Discovery Approach to Scientific Innovation
July 16, 2021Ethos Discovery is committed to the process of starting with an unmet clinical need to determine trial prioritization for both basic research as well as later stage research. Through this “unmet need” approach, we expect to deliver cures to diseases such as canine hemangiosarcoma, sepsis, and other complex medical problems in pet animals.
Read Article -
Ethos-PUSH – Studying the Genome and Epigenetic Alterations
June 30, 2021Through the Ethos-PUSH study we will be studying genetic and epigenetic alterations in tumor samples with the goal of proposing novel therapeutic options, that will be vital in curing hemangiosarcoma in dogs.
Read Article -
Minimally invasive surgery and the GP: Getting started
June 23, 2021Veterinary surgeon Chris Thomson answers some common questions regarding learning curves, feasibility, how to get started, and basic equipment needs for a veterinarian in general practice, to make the leap into the world of minimally invasive surgery.
Read Article -
The Microbiome as a Functional Organ
June 2, 2021Ethos Discovery's ultimate goal is to discover and develop novel diagnostics and therapeutics for intestinal dysbiosis, and ultimately to be able to predict and even prevent certain chronic diseases. This will lead to prolonged lifespan and health-span for domestic animals and also for human beings.
Read Article -
Ethos Discovery vs Canine Hemangiosarcoma
February 12, 2021Ethos-PUSH will serve as the largest collection of canine hemangiosarcoma biospecimens in the world. These biospecimens will be made available to independent collaborators with the goal of further understanding the genomics, epigenomics, and biology of hemangiosarcoma.
Read Article -
Diagnosis, Treatment and Future Study Direction in Dogs with Intestinal Dysbiosis
September 11, 2020A patient with intestinal dysbiosis can have decreased appetite, diarrhea, vomiting, or a variety of other clinical signs.
Read Article -
Hemangiosarcoma – Developing New Treatment Options
August 12, 2020Ethos Discovery hopes to improve the outcome for dogs with hemangiosarcoma and take a similar path as to that of human childhood leukemia, which through significant research efforts went from a commonly fatal disease to a commonly cured disease.
Read Article
Loading